CAPR - Capricor Therapeutics Inc.'s (CAPR) CEO Linda Marbán on Q1 2021 Results - Earnings Call Transcript
Capricor Therapeutics, Inc. (CAPR) Q1 2021 Earnings Conference Call May 13, 2021, 4:30 PM ET Company Participants AJ Bergmann - Chief Financial Officer Linda Marbán - Chief Executive Officer Conference Call Participants Alan Leong - BioWatch News Presentation Operator Greetings. And welcome to Capricor Therapeutics First Quarter 2021 Earnings and Corporate Update Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference call is being recorded. I’d now like to turn the conference over to your host, Mr. AJ Bergmann. Thank you. You may begin. AJ Bergmann Thank you. Before we start, I would like to state that we will be making certain forward-looking statements during today’s presentation. These statements may include statements regarding, among other things, the efficacy, safety and intended utilization of our product candidates, our future research and development plans, including
For further details see:
Capricor Therapeutics, Inc.'s (CAPR) CEO Linda Marbán on Q1 2021 Results - Earnings Call Transcript